PT - JOURNAL ARTICLE AU - Nita Bharti AU - Brian Lambert AU - Cara Exten AU - Christina Faust AU - Matt Ferrari AU - Anthony Robinson TI - Large university with high COVID-19 incidence did not increase risk to non-student population AID - 10.1101/2021.04.27.21255023 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.27.21255023 4099 - http://medrxiv.org/content/early/2021/04/29/2021.04.27.21255023.short 4100 - http://medrxiv.org/content/early/2021/04/29/2021.04.27.21255023.full AB - Large US colleges and universities that re-opened campuses in the fall of 2020 and the spring of 2021 experienced high per capita rates of COVID-19. Returns to campus were controversial because they posed a risk to the surrounding communities. A large university in Pennsylvania that returned to in-person instruction in the fall of 2020 and spring of 2021 reported high incidence of COVID-19 among students. However, the co-located non-student resident population in the county experienced fewer COVID-19 cases per capita than reported in neighboring counties. Activity patterns from mobile devices indicate that the non-student resident population near the university restricted their movements during the pandemic more than residents of neighboring counties. Preventing cases in student and non-student populations requires different, specifically targeted strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge financial support from Penn State University Huck Institutes of the Life Sciences and the Institute for Computational and Data Sciences. The funding sources had no role in the study design, execution or interpretation of the results.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our work with the anonymized and aggregated data provided by SafeGraph and used in the study does not quality as human subjects research as defined by the university IRB. SafeGraph approved the use of their data for this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used that were freely available in the public domain can be found at the links below: https://www.health.pa.gov/topics/disease/coronavirus/pages/cases.aspx https://virusinfo.psu.edu/covid-19-dashboard/ https://www.census.gov/data/developers/data-sets/acs-5year.html Academic researchers must register to receive access to SafeGraph data at no charge for non-commercial purposes only here: https://www.safegraph.com/academics